Literature DB >> 2473846

Rat T-cell lines specific to a nonimmunodominant determinant of a retinal protein (IRBP) produce uveoretinitis and pinealitis.

L H Hu1, T M Redmond, H Sanui, T Kuwabara, C G McAllister, B Wiggert, G J Chader, I Gery.   

Abstract

Rat lymphocyte lines were established, with specificity toward two synthetic peptides derived from the interphotoreceptor retinoid-binding protein (IRBP), which specifically localizes in the retina and pineal gland. One of the peptides, R4, is immunopathogenic, producing experimental autoimmune uveoretinitis (EAU) and pinealitis (EAP) in immunized rats, while the other peptide, R3, exhibits no detectable immunopathogenicity in rats. The cell lines carry surface markers specific for the helper/inducer subset of T-lymphocytes. When tested by the proliferation assay, the line cells demonstrated major histocompatibility-restricted vigorous responses against the immunizing (homologous) peptide, but failed to recognize the intact IRBP molecule. This finding is in line with other data indicating that peptides R3 and R4 are nonimmunodominant determinants of IRBP for the Lewis rat. Yet, the cell lines specific for R4 were highly immunopathogenic, producing EAU and EAP in naive rats at numbers as low as 0.25 x 10(6), with histopathological changes similar to those induced by active immunization with this peptide. The immunological capacity of the cell lines was further demonstrated by the finding that spleen cells from recipient rats of these lines responded well against the homologous peptides. The uniqueness of this system, in which lymphocytes specific toward a nondominant determinant are immunopathogenic, is underscored and the possible mechanisms of disease induction are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2473846     DOI: 10.1016/0008-8749(89)90165-2

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  5 in total

1.  IL-22-induced regulatory CD11b+ APCs suppress experimental autoimmune uveitis.

Authors:  Yan Ke; Deming Sun; Guomin Jiang; Henry J Kaplan; Hui Shao
Journal:  J Immunol       Date:  2011-07-27       Impact factor: 5.422

2.  Anti-CD3 antibody ameliorates experimental autoimmune uveitis by inducing both IL-10 and TGF-β dependent regulatory T cells.

Authors:  Yan Ke; Guomin Jiang; Deming Sun; Henry J Kaplan; Hui Shao
Journal:  Clin Immunol       Date:  2011-01-21       Impact factor: 3.969

Review 3.  Experimental autoimmune uveitis: molecular mimicry and oral tolerance.

Authors:  V K Singh; K Nagaraju
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

4.  IFN-β inhibits the increased expression of IL-9 during experimental autoimmune uveoretinitis.

Authors:  Yan Yang; Liping Du; Min Sun; Aize Kijlstra; Peizeng Yang
Journal:  PLoS One       Date:  2012-10-30       Impact factor: 3.240

5.  A pathogenic autoimmune process targeted at a surrogate epitope.

Authors:  A T Kozhich; Y Kawano; C E Egwuagu; R R Caspi; R K Maturi; J A Berzofsky; I Gery
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.